Regulatory Framework and Surveillance Systems Ensuring Blood Supply Safety in the United States
Volume 40 Number 2 | April 2026 Summary The article outlines the FDA’s comprehensive regulatory framework ensuring the safety of the U.S. blood supply through strict donor eligibility criteria, infectious disease testing, and routine inspections. It highlights updates to the Donor History Questionnaire, the shift to individualized risk‑based screening, and the TTIMS surveillance system, which…








